Boston Scientific, a global medical technology company, will acquire Bard, the electrophysiology (EP) business of C.R. Bard, for $275 million in cash.

With nearly 180 employees worldwide, Bard offers advanced therapeutic catheters, diagnostic catheters, electrophysiology recording systems and intracardiac access devices.

Bard would become part of the existing Boston Scientific business within the company's rhythm management unit.